BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 11449838)

  • 41. MicroRNA profiling can classify acute leukemias of ambiguous lineage as either acute myeloid leukemia or acute lymphoid leukemia.
    de Leeuw DC; van den Ancker W; Denkers F; de Menezes RX; Westers TM; Ossenkoppele GJ; van de Loosdrecht AA; Smit L
    Clin Cancer Res; 2013 Apr; 19(8):2187-96. PubMed ID: 23444217
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Aberrant expression of immunoglobulin germline gene C mu in leukemias].
    Guo M; Dong L; Huang S
    Zhonghua Xue Ye Xue Za Zhi; 1998 Jul; 19(7):359-62. PubMed ID: 11189519
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Impact of immunophenotyping on management of acute leukemias.
    Béné MC; Bernier M; Castoldi G; Faure GC; Knapp W; Ludwig WD; Matutes E; Orfao A; van't Veer M
    Haematologica; 1999 Nov; 84(11):1024-34. PubMed ID: 10553164
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [A minimal residual population of leukemic cells in patients with acute myeloid leukemias].
    Gal'tseva IV; Parovichnikova EN; Savchenko VG
    Ter Arkh; 1997; 69(7):74-9. PubMed ID: 9424769
    [No Abstract]   [Full Text] [Related]  

  • 45. [Modern approach to diagnosis and therapy in childhood leukemias].
    Hasanbegović E
    Med Arh; 2004; 58(1):59-60. PubMed ID: 15017909
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Usefulness of beta-glucuronidase activity determination in the differential diagnosis of acute leukemia].
    Litwin J; Kołakowska-Polubiec K; Polubiec A; Rokicka R; Bieleckiej B
    Acta Haematol Pol; 1978; 9(2):121-4. PubMed ID: 276243
    [TBL] [Abstract][Full Text] [Related]  

  • 47. DNA fingerprinting in the detection of residual disease in acute leukemia.
    Pakkala S
    Leukemia; 1991 May; 5(5):437-40. PubMed ID: 2033965
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Molecular diagnosis and clinical decisions in adult acute leukemia.
    Appelbaum FR
    Semin Hematol; 1999 Oct; 36(4):401-10. PubMed ID: 10530721
    [TBL] [Abstract][Full Text] [Related]  

  • 49. AML-M0: a review of laboratory features and proposal of new diagnostic criteria.
    Stasi R; Amadori S
    Blood Cells Mol Dis; 1999 Apr; 25(2):120-9. PubMed ID: 10389594
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hypermethylation of calcitonin gene in adult acute leukemia at diagnosis and during complete remission.
    Thomas X; Teillon MH; Belhabri A; Rimokh R; Fiere D; Magaud JP; Archimbaud E
    Hematol Cell Ther; 1999 Feb; 41(1):19-26. PubMed ID: 10193642
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Osteoarticular manifestations as initial presentation of acute leukemias in children and adolescents in Bahia, Brazil.
    Robazzi TC; Barreto JH; Silva LR; Santiago MB; Mendonça N
    J Pediatr Hematol Oncol; 2007 Sep; 29(9):622-6. PubMed ID: 17805037
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Acute leukemias: a paradigm for the integration of new technologies in diagnosis and classification.
    Willman CL
    Mod Pathol; 1999 Feb; 12(2):218-28. PubMed ID: 10071344
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Detection of minimal residual disease in acute leukemia.
    Sievers EL; Radich JP
    Curr Opin Hematol; 2000 Jul; 7(4):212-6. PubMed ID: 10882176
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Molecular diagnostics in acute leukemias.
    Bacher U; Schnittger S; Haferlach C; Haferlach T
    Clin Chem Lab Med; 2009; 47(11):1333-41. PubMed ID: 19817644
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Clinical application of gene technology for diagnosis and treatment of leukemia].
    Hashino S; Imamura M
    Rinsho Byori; 1997 Jan; 45(1):58-65. PubMed ID: 9022344
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Screening for CRLF2 overexpression in adult acute lymphoblastic leukemia.
    Haslam K; Kelly J; Morris T; Connaghan G; Gilligan O; Browne P; Langabeer SE
    Int J Lab Hematol; 2011 Dec; 33(6):e17-9. PubMed ID: 21457190
    [No Abstract]   [Full Text] [Related]  

  • 57. Isolated asymptomatic severe neutropenia as the presentation of myeloid/natural killer cell acute leukemia.
    Rubio-Batllés M; de La Mata AC; Romero Macias JR; Vitaller AR
    Haematologica; 2000 Mar; 85(3):322-4. PubMed ID: 10702827
    [No Abstract]   [Full Text] [Related]  

  • 58. Identification of similarities and differences between myeloid and lymphoid acute leukemias using a gene-gene interaction network.
    Chen J; Huang C; Zhu Y; Dong L; Cao W; Sun L; Sun H; Wan D; Liu Y; Zhang Z; Wang C
    Pathol Res Pract; 2015 Oct; 211(10):789-96. PubMed ID: 26296916
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Diagnosis of childhood acute myeloid leukemia.
    Behm FG
    Clin Lab Med; 1999 Mar; 19(1):187-237, vii. PubMed ID: 10403081
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Detection of minimal residual leukemic cells in acute leukemia].
    Irimajiri K
    Rinsho Ketsueki; 1990 Apr; 31(4):409-15. PubMed ID: 2199697
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.